ESSA Pharma Inc (EPIX)

6.66 +0.25 (+3.90%) USD  |  NASDAQ  |  May 01, 16:00
6.66 0.00 (0.00%) After-Hours: 20:00
More

ESSA Pharma Research and Development Expense (Quarterly): 5.377M for Dec. 31, 2023

Research and Development Expense (Quarterly) Chart

Historical Research and Development Expense (Quarterly) Data

View and export this data back to 2013. Upgrade now.
Date Value
December 31, 2023 5.377M
September 30, 2023 5.226M
June 30, 2023 6.271M
March 31, 2023 4.481M
December 31, 2022 5.344M
September 30, 2022 4.352M
June 30, 2022 6.394M
March 31, 2022 7.650M
December 31, 2021 6.020M
September 30, 2021 6.273M
June 30, 2021 6.232M
March 31, 2021 7.268M
December 31, 2020 4.486M
September 30, 2020 2.237M
June 30, 2020 2.704M
March 31, 2020 4.618M
December 31, 2019 2.587M
September 30, 2019 2.005M
June 30, 2019 1.951M
March 31, 2019 1.454M
December 31, 2018 1.286M
Date Value
September 30, 2018 0.9268M
June 30, 2018 0.9878M
March 31, 2018 1.989M
December 31, 2017 0.9696M
September 30, 2017 1.166M
June 30, 2017 2.920M
March 31, 2017 2.549M
December 31, 2016 -0.9085M
September 30, 2016 3.952M
June 30, 2016 3.363M
March 31, 2016 2.544M
December 31, 2015 3.201M
September 30, 2015 -0.7918M
June 30, 2015 2.591M
March 31, 2015 2.533M
December 31, 2014 0.6445M
September 30, 2014 -0.1089M
June 30, 2014 0.6127M
March 31, 2014 0.0284M
December 31, 2013 0.0991M

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

1.951M
Minimum
Jun 2019
7.650M
Maximum
Mar 2022
4.814M
Average
5.226M
Median
Sep 2023

Research and Development Expense (Quarterly) Benchmarks

Acasti Pharma Inc 1.443M
Aurinia Pharmaceuticals Inc 10.23M
Edesa Biotech Inc 0.7045M
Lexaria Bioscience Corp 0.2458M
Xenon Pharmaceuticals Inc 41.08M